-
Je něco špatně v tomto záznamu ?
Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer patients and healthy controls
J. Slyskova, A. Naccarati, B. Pardini, V. Polakova, L. Vodickova, Z. Smerhovsky, M. Levy, L. Lipska, V. Liska, P. Vodicka,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
Grantová podpora
NS10230
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Free Medical Journals
od 1996 do Před 1 rokem
Open Access Digital Library
od 1996-01-01
Medline Complete (EBSCOhost)
od 1996-01-01 do Před 1 rokem
PubMed
22294771
DOI
10.1093/mutage/ger088
Knihovny.cz E-zdroje
- MeSH
- celogenomová asociační studie MeSH
- DNA vazebné proteiny genetika MeSH
- dospělí MeSH
- genotyp MeSH
- kolorektální nádory diagnóza genetika MeSH
- kometový test MeSH
- kvantitativní polymerázová řetězová reakce MeSH
- lidé středního věku MeSH
- lidé MeSH
- messenger RNA genetika MeSH
- oprava DNA genetika MeSH
- polymorfismus genetický genetika MeSH
- poškození DNA genetika MeSH
- prognóza MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- studie případů a kontrol MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
Alteration of DNA integrity is a potential cause of cancer and it is assumed that reduced DNA repair capacity and accumulation of DNA damage may represent intermediate markers in carcinogenesis. In this case-control study, DNA damage and nucleotide excision repair capacity (NER-DRC) were assessed in association with sporadic colorectal cancer (CRC). Both parameters were quantified by comet assay in blood cells of 70 untreated incident patients and 70 age-matched healthy controls. mRNA expression and polymorphisms in relevant NER genes were concurrently analyzed. The aim of this study was to characterize incident CRC patients for NER-DRC and to clarify possible relations between investigated variables. Comet assay and mRNA expression analysis showed that CRC patients differ in repair capacity as compared to controls. Patients had a lower NER-DRC and simultaneously they exhibited higher endogenous DNA damage (for both P < 0.001). Accumulation of DNA damage and decreasing NER-DRC behaved as independent modulating parameters strongly associated with CRC. Expression levels of 6 out of 9 studied genes differed between groups (P ≤ 0.001), but none of them was related to DRC or to any of the studied NER polymorphisms. However, in patients only, XPC Ala499Val modulated expression levels of XPC, XPB and XPD gene, whereas XPC Lys939Gln was associated with XPA expression level in controls (for all P < 0.05). This study provides evidence on altered DRC and DNA damage levels in sporadic CRC and proposes the relevance of the NER pathway in this malignancy. Further, alterations in a complex multigene process like DNA repair may be better characterized by functional quantification of repair capacity than by quantification of individual genes transcripts or gene variants alone.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12024062
- 003
- CZ-PrNML
- 005
- 20140827094933.0
- 007
- ta
- 008
- 120815s2012 enk f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1093/mutage/ger088 $2 doi
- 035 __
- $a (PubMed)22294771
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Slyskova, Jana $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Science of the Czech Republic, Videnska 1083, 14220 Prague, Czech Republic.
- 245 10
- $a Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer patients and healthy controls / $c J. Slyskova, A. Naccarati, B. Pardini, V. Polakova, L. Vodickova, Z. Smerhovsky, M. Levy, L. Lipska, V. Liska, P. Vodicka,
- 520 9_
- $a Alteration of DNA integrity is a potential cause of cancer and it is assumed that reduced DNA repair capacity and accumulation of DNA damage may represent intermediate markers in carcinogenesis. In this case-control study, DNA damage and nucleotide excision repair capacity (NER-DRC) were assessed in association with sporadic colorectal cancer (CRC). Both parameters were quantified by comet assay in blood cells of 70 untreated incident patients and 70 age-matched healthy controls. mRNA expression and polymorphisms in relevant NER genes were concurrently analyzed. The aim of this study was to characterize incident CRC patients for NER-DRC and to clarify possible relations between investigated variables. Comet assay and mRNA expression analysis showed that CRC patients differ in repair capacity as compared to controls. Patients had a lower NER-DRC and simultaneously they exhibited higher endogenous DNA damage (for both P < 0.001). Accumulation of DNA damage and decreasing NER-DRC behaved as independent modulating parameters strongly associated with CRC. Expression levels of 6 out of 9 studied genes differed between groups (P ≤ 0.001), but none of them was related to DRC or to any of the studied NER polymorphisms. However, in patients only, XPC Ala499Val modulated expression levels of XPC, XPB and XPD gene, whereas XPC Lys939Gln was associated with XPA expression level in controls (for all P < 0.05). This study provides evidence on altered DRC and DNA damage levels in sporadic CRC and proposes the relevance of the NER pathway in this malignancy. Further, alterations in a complex multigene process like DNA repair may be better characterized by functional quantification of repair capacity than by quantification of individual genes transcripts or gene variants alone.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a kolorektální nádory $x diagnóza $x genetika $7 D015179
- 650 _2
- $a kometový test $7 D020552
- 650 _2
- $a poškození DNA $x genetika $7 D004249
- 650 _2
- $a oprava DNA $x genetika $7 D004260
- 650 _2
- $a DNA vazebné proteiny $x genetika $7 D004268
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a celogenomová asociační studie $7 D055106
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a polymorfismus genetický $x genetika $7 D011110
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a messenger RNA $x genetika $7 D012333
- 650 _2
- $a kvantitativní polymerázová řetězová reakce $7 D060888
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Naccarati, Alessio
- 700 1_
- $a Pardini, Barbara
- 700 1_
- $a Polakova, Veronika
- 700 1_
- $a Vodickova, Ludmila
- 700 1_
- $a Smerhovsky, Zdenek
- 700 1_
- $a Levy, Miroslav
- 700 1_
- $a Lipska, Ludmila
- 700 1_
- $a Liska, Vaclav
- 700 1_
- $a Vodicka, Pavel
- 773 0_
- $w MED00003429 $t Mutagenesis $x 1464-3804 $g Roč. 27, č. 2 (2012), s. 225-32
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22294771 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120815 $b ABA008
- 991 __
- $a 20140827095316 $b ABA008
- 999 __
- $a ok $b bmc $g 946210 $s 781390
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 27 $c 2 $d 225-32 $i 1464-3804 $m Mutagenesis $n Mutagenesis $x MED00003429
- GRA __
- $a NS10230 $p MZ0
- LZP __
- $a Pubmed-20120815/12/02